Zosano Pharma

$1.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (+11.11%) Today

-$0.04 (-2.86%) As of 11:10 PM UTC after-hours

Why Robinhood?

You can buy or sell Zosano Pharma and other stocks, options, and ETFs commission-free!

About ZSAN

Zosano Pharma Corporation Common Stock, also called Zosano Pharma, is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. The firm focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. It offers Qtrypta, a formulation of zolmitriptan delivered utilizing the intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. The listed name for ZSAN is Zosano Pharma Corporation Common Stock.

CEO

Steven Lo

Employees

Headquarters

Fremont, California

Founded

2006

Market Cap

143.86M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

30.28M

High Today

$1.57

Low Today

$1.27

Open Price

$1.27

Volume

7.17M

52 Week High

$3.06

52 Week Low

$0.3275

ZSAN Earnings

-$0.58

-$0.39

-$0.19

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 11, After Hours